Corrigendum: Hallmarks of pluripotency (Nature (2015) 525 (469-478) DOI: 10.1038/nature15515);Hallmarks of pluripotency

Nature

Volumn 525, Issue 7570, 2015, Pages 469-478

  De Los Angeles, Alejandro ^a,b,c   Ferrari, Francesco ^d   Xi, Ruibin ^d,e   Fujiwara, Yuko ^a,b,c   Benvenisty, Nissim ^f   Deng, Hongkui ^e   Hochedlinger, Konrad ^b,c,d,g   Jaenisch, Rudolf ^h   Lee, Soohyun ^d   Leitch, Harry G ⁱ   Lensch, M William ^a,b,c   Lujan, Ernesto ^j   Pei, Duanqing ^k   Rossant, Janet ^l   Wernig, Marius ^j   Park, Peter J ^d   Daley, George Q ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e PEKING UNIVERSITY   (China)

^f HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^g MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^h WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

^j STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^l HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; OCTAMER TRANSCRIPTION FACTOR 4; RNA; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

BIOASSAY; BIOENGINEERING; CELLS AND CELL COMPONENTS; GENOMICS; METABOLISM; REGENERATION;

BLASTOCYST; CELL DIFFERENTIATION; CELL RENEWAL; CHIMERA; DNA SEQUENCE; ECTODERM; EMBRYONIC STEM CELL; EPIBLAST STEM CELL; EXOME; FIBROBLAST; GENE SEQUENCE; GENOMICS; GENOTYPE; GERMLINE STEM CELL; HUMAN; INNER CELL MASS; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPRODUCIBILITY; REVIEW; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC CELL; TETRAPLOIDY; ANIMAL; CYTOLOGY; METABOLISM;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; GENOMICS; HUMANS; PLURIPOTENT STEM CELLS;

EID: 84942531803     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature16470     Document Type: Erratum

References (114)

1. Kelly, S. J. Studies of the developmental potential of 4-and 8-cell stage blastomeres. J. Exp. Zool. 200, 365-376 (1977).
2. Gurdon, J. B. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J. Embryol. Exp. Morphol. 10, 622-640 (1962).
3. Takahashi, K., Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
4. Stevens, L. C. Studies on transplantable testicular teratomas of strain 129mice. J. Natl. Cancer Inst. 20, 1257-1275 (1958).
5. Evans, M. J., Kaufman,M. H. Establishment inculture of pluripotential cells from mouse embryos. Nature 292, 154-156 (1981).
6. Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stemcells. Proc. Natl Acad. Sci. USA 78, 7634-7638 (1981).
7. Thomson, J. A. et al. Embryonic stem cells derived from human blastocysts. Science 282, 1145-1147 (1998).
8. Thomson, J. A. et al. Isolation of a primate embryonic stem cell line. Proc. Natl Acad. Sci. USA 92, 7844-7848 (1995).
9. Brons, I. G. et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191-195 (2007).
10. Tesar, P. J. et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196-199 (2007).
11. Matsui, Y., Zsebo,K., Hogan, B. L. M.Derivation of pluripotentialembryonic stem cells from murine primordial germ cells in culture. Cell 70, 841-847 (1992).
12. Kanatsu-Shinohara, M. et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell 119, 1001-1012 (2004).
13. Ko, K. et al. Induction of pluripotency in adult unipotent germline stemcells. Cell Stem Cell 5, 87-96 (2009).
14. Boroviak, T. et al. The ability of inner-cell-mass cells to self-renew as embryonic stem cells following epiblast specification. Nature Cell Bio. 16, 516-528 (2014).
15. Nichols, J., Smith, A. Naive and primed pluripotent states. Cell Stem Cell 4, 487-492 (2009).
16. Tachibana,M. et al. Generation of chimeric rhesusmonkeys. Cell 148, 285-295 (2012).
17. Boyer, L. A. et al. Core regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 (2005).
18. Loh, Y.H. et al. The Oct4 andNanog transcription network regulates pluripotency in mouse embryonic stem cells. Nature Genet. 38, 431-440 (2006).
19. Nichols, J. et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391 (1998).
20. Chambers, I. et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655 (2003).
21. Mitsui, K. et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642 (2003).
22. Avilion, A. A. et al. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17, 126-140 (2003).
23. Masui, S. et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stemcells. Nature Cell Biol. 9, 625-635 (2007).
24. Wang, Z., Oron, E., Nelson, B., Razis, S., Ivanova, N. Distinct lineage specification roles forNANOG,OCT4, SOX2in human embryonic stemcells. Cell StemCell 10, 440-454 (2012).
25. Chambers, I. et al. Nanog safeguards pluripotency and mediates germline development. Nature 450, 1230-1234 (2007).
26. Silva, J. et al. Nanog is the gateway to the pluripotent ground state. Cell 138, 722-737 (2009).
27. Chen, X. et al. Integration of external signaling pathway with the core transcriptional network in embryonic stem cells. Cell 133, 1106-1117 (2008).
28. Kim, J., Chu, J., Shen, X., Wang, J., Orkin, S. H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132, 1049-1061 (2008).
29. Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326 (2006).
30. Leitch, H. G. et al. Naive pluripotency is associated with global DNA hypomethylation. Nature Struct. Mol. Biol. 20, 311-316 (2013).
31. Guo, G. et al. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 136, 1063-1069 (2009).
32. Bao, S. et al. Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells. Nature 461, 1292-1295 (2009).
33. Dunn, S. J., Martello, G., Yordanov, B., Emmott, S., Smith, A. G. Defining an essential transcription factor program for naive pluripotency. Science 344, 1156-1160 (2014).
34. Ying, Q. L. et al. The groundstate ofembryonic stemcell self-renewal.Nature453, 519-523 (2008).
35. Marks, H. et al. The transcriptional and epigenomic foundations of ground state pluripotency. Cell 149, 590-604 (2012).
36. Smith, Z. D. et al. A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature 484, 339-344 (2012).
37. Wu, J. et al. An alternative pluripotent state confers interspecies chimeric competency. Nature 521, 316-321 (2015).
38. Kumar, R. M. et al. Deconstructing transcriptional heterogeneity in pluripotent stem cells. Nature 516, 56-61 (2014).
39. Morgani, S. M. et al. Totipotent embryonic stem cells arise in ground-state culture conditions. Cell Rep. 3, 1945-1957 (2013).
40. Chamberlain, S. J., Yee, D., Magnuson, T. Polycomb repressive complex 2 is dispensable for maintenance of embryonic stem cell pluripotency. Stem Cells 26, 1496-1505 (2008).
41. Okano, M., Bell, D. W., Habeer, D. A., Li, E. DNAmethyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257 (1999).
42. Li, E., Bestor, T. H., Jaenisch, R. Target mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926 (1992).
43. Tsumura, A. et al. Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a, Dnmt3b. Genes Cells 11, 805-814 (2006).
44. Beard, C., Li, E., Jaenisch, R. Loss of methylation activates XIST in somatic but not in embryonic cells. Genes Dev. 9, 2325-2334 (1995).
45. Liao, J. et al. Targeted disruption of DNMT1, DNMT3A, DNMT3B in human embryonic stem cells. Nature Genet. 47, 469-478 (2015).
46. Chan, E. M. et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nature Biotechnol. 27, 1033-1037 (2009).
47. Nagy, A., Gocza, E. et al. Embryonic stem cells alone are able to support fetal development in the mouse. Development 110, 815-821 (1990).
48. Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., Roder, J. C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl Acad. Sci. USA 90, 8424-8428 (1993).
49. Wang, Z., Jaenisch, R. At most three ES cells contribute to the somatic lineages of chimeric mice produced by ES-tetraploid complementation. Dev. Biol. 275, 192-201 (2004).
50. Huang, Y., Osorno, R., Tsakiridis, A., Wilson, V. In vivo differentiation potential of epiblast stem cells revealed by chimeric embryo formation. Cell Rep. 2, 1571-1578 (2012).
51. Hanna, J. et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc. Natl Acad. Sci. USA 107, 9222-9227 (2010).
52. Gafni, O. et al. Derivation of novel human ground state naive pluripotent stem cells. Nature 504, 282-286 (2013).
53. Theunissen, T. W. et al. Systematic identification of culture conditions for induction and maintenance of naive human pluriptoency. Cell Stem Cell 15, 471-487 (2014).
54. Takashima, Y. et al. Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 158, 1254-1269 (2014).
55. James, D., Noggle, S. A., Swigut, T., Brivanlou, A. H. Contribution of human embryonic stem cells to mouse blastocyst. Dev. Biol. 295, 90-102 (2006).
56. Fang, R. et al. Generation of naive induced pluripotent stem cells from rhesus monkey fibroblasts. Cell Stem Cell 15, 488-496 (2014).
57. Chen, Y. et al. Generation of cynomolgus monkey chimeric fetuses using embryonic stem cells. Cell Stem Cell 17, 116-124 (2015).
58. Guo, H. et al. The DNA methylation landscape of human early embryos. Nature 511, 606-610 (2014).
59. Smith, Z. D. et al. DNA methylation dynamics of the human preimplantation embryo. Nature 511, 611-615 (2014).
60. Yan, L. et al. Single-cell RNA-seq profiling of human preimplantation embryos and embryonic stem cells. Nature Struct. Mol. Biol. 20, 1131-1139 (2013).
61. Okamoto, I. et al. Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development. Nature 472, 370-374 (2011).
62. O'Leary, T. et al. Tracking the progression of the human inner cell mass during embryonic stem cell derivation. Nature Biotechnol. 30, 278-282 (2012).
63. Silva, S. S., Rowntree, R. K.,Mekhoubad, S., Lee, J. T. X-chromosomeinactivation and epigenetic fluidity in human embryonic stemcells. Proc. Natl Acad. Sci. USA 105, 4820-4825 (2008).
64. Anguera, M. C. et al. Molecular signatures of human induced pluripotent stem cells highlight sex differencesandcancer genes. Cell StemCell11,75-90(2012).
65. Chan, Y. S. et al. Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast. Cell Stem Cell 13, 663-675 (2013).
66. Ware, C. B. et al. Derivation of naive humanembryonic stemcells. Proc. Natl Acad. Sci. USA 111, 4484-4489 (2014).
67. Valamehr, B. et al. Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells. Stem Cell Rep. 2, 366-381 (2014).
68. Leitch, H. G. et al. Rebuilding pluripotency fromprimordial germcells. Stem Cell Rep. 1, 66-78 (2013).
69. Hou, P. et al. Pluripotent stemcells induced frommouse somatic cells by smallmolecule compounds. Science 341, 651-654 (2013).
70. Shamblott, M. J. et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl Acad. Sci. USA 95, 13726-13731 (1998).
71. Conrad, S. et al. Generation of pluripotent stem cells from adult human testis. Nature 456, 344-349 (2008);
72. Retraction 512, 338 (2014).
73. Ko, K. et al. Human adult germline stemcells in question. Nature 465, E1 (2010).
74. Reyes,M., Verfaillie, C. M.Characterization ofmultipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann. NY Acad. Sci. 938, 231-235 (2001).
75. Jiang, Y. et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49 (2002).
76. Kucia, M. et al. A population of very small embryonic-like (VSEL) CXCR41SSEA-11Oct41 stem cells identified in adult bone marrow. Leukemia 20, 857-869 (2006).
77. Kuroda, Y. et al. Isolation, culture, evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nature Protocols 8, 1391-1415 (2013).
78. Roy, S. et al. Rare somatic cells from human breast tissue exhibit extensive lineage plasticity. Proc. Natl Acad. Sci. USA 110, 4598-4603 (2013).
79. Nicholas, J., Hall, B. Experiments on developing rats: II. The development of isolated blastomeres and fused eggs. J. Exp. Zool. 90, 441-459 (1942).
80. Tarkowski, A. K. Experiments on the development of isolated blastomeres of mouse eggs. Nature 184, 1286-1287 (1959).
81. Willadsen, S. M., Polge, C. Attempts to produce monozygotic quadruplets in cattle by blastomere separation. Vet. Rec. 108, 211-213 (1981).
82. Mitalipov, S.M. et al. Monozygotic twinning in rhesusmonkeys by manipulation of in vitro-derived embryos. Biol. Reprod. 66, 1449-1455 (2002).
83. Rossant, J. Postimplantation development of blastomeres isolated from 4-and 8-cell mouse eggs. J. Embryol. Exp. Morphol. 36, 283-290 (1976).
84. Van de Velde, H., Cauffman, G., Tournaye, H., Devroey, P., Liebaers, I. The four blastomeres of a 4-cell stagehumanembryo are able to develop individually into blastocysts with inner cell mass and trophectoderm. Hum. Reprod. 23, 1742-1747 (2008).
85. Ng, R. K. et al. Epigenetic restriction of embryonic cell lineage fate bymethylation of Elf5. Nature Cell Biol. 10, 1280-1290 (2008).
86. Macfarlan, T. S. et al. Embryonic stem cell potency fluctuates with endogenous retrovirus activity. Nature 487, 57-63 (2012).
87. Abad, M. et al. Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 502, 340-345 (2013).
88. Xu, R. H. et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nature Biotechnol. 20, 1261-1264 (2002).
89. Bernardo, A. S. et al. BRACHYURY and CDX2 mediate BMP-induced differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages. Cell Stem Cell 9, 144-155 (2011).
90. Mikkelsen, T. S. et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55 (2008).
91. Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290 (2010).
92. Yu, M. et al. A resource for cell line authentication, annotation,quality control. Nature 520, 307-311 (2015).
93. De Los Angeles, A. et al. Failure to replicate the STAP cell phenomenon. Nature http://dx.doi.org/10.1038/nature15513 (this issue).
94. RIKEN. Report on STAP Cell Research Paper Investigation http://www3.riken.jp/stap/e/c13document52.pdf (2014).
95. Konno, D. et al. STAP cells are derived from ES cells. Nature http://dx.doi.org/10.1038/nature15366 (this issue).
96. Tachibana,M. et al.Human embryonic stemcells derived by somatic cell nuclear transfer. Cell 153, 1228-1238 (2013).
97. Ma, H. et al.Humanoocytes reprogramadultsomatic nuclei of a type I diabetic to diploid pluripotent stem cells. Nature 511, 177-183 (2014).
98. Kim, K. et al. Histocompatibleembryonic stemcells by parthenogenesis. Science 315, 482-486 (2007).
99. Kim,K. et al.Recombination signatures distinguishembryonic stemcells derived by parthenogenesis and somatic cell nuclear transfer. Cell Stem Cell 1, 346-352 (2007).
100. Ohtsuka, S., Nishikawa-Torikai, S., Niwa, H. E-cadherin promotes incorporation of mouse epiblast stem cells into normal development. PLoS ONE 7, e45220 (2012).
101. Cacchiarelli, D. et al. Integrative analyses of human reprogramming reveal dynamic nature of induced pluripotency. Cell 162, 412-424 (2015).
102. Narasimha, M.,Barton, S. C., Surani,M. A. The role of the paternal genome in the development of the mouse germ line. Curr. Biol. 7, 881-884 (1997).
103. Wakayama, S. et al. Efficient establishment of mouse embryonic stem cell lines from single blastomeres and polar bodies. Stem Cells 25, 986-993 (2007).
104. Resnick, J. L., Bixler, L. S., Cheng, L., Donovan, P. J. Long-term proliferation of mouse germ cells in culture. Nature 359, 550-551 (1992).
105. Seandel, M. et al. Generation of functional multipotent adult stem cells from GPR1251 germline progenitors. Nature 449, 346-350 (2007).
106. Munsie, M. J. et al. Isolation of pluripotent embryonic stem cells from reprogrammed adultmouse somatic cell nuclei. Curr. Biol. 10, 989-992 (2000).
107. Andrews, P. W., Bronson, D. L., Benham, F., Strickland, S., Knwles, B. B. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int. J. Cancer 26, 269-280 (1980).
108. Revazova, E. S. et al. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 9, 432-439 (2007).
109. Klimanskaya, I.,Chung, Y., Becker, S., Lu, S. J., Lanza,R.Humanembryonic stem cell lines derived from single blastomeres. Nature 444, 481-485 (2006).
110. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
111. ISSCR. Guidelines for the conduct of human embryonic stem cell research http://www.isscr.org/docs/default-source/hesc-guidelines/isscrhescguidelines2006.pdf (2006).
112. Mü ller, F.-J. et al. A bioinformatics assay for pluripotency in human cells. Nature Methods 8, 315-317 (2011).
113. Cahan, P. et al. CellNet: network biology applied to stem cell engeineering. Cell 158, 903-915 (2014).
114. International Cell Line Authentication Committee. Guide to human cell line authentication (2012 http://standards.atcc.org/kwspub/home/the-international-cell-line-authentication-committee-iclac-/Authentication-SOP.pdf.